Professor KEVIN GASTON Kevin.Gaston@nottingham.ac.uk
Professor of Cancer Studies
Combination of progesterone and mifepristone for cancer therapy
Gaston, Kevin
Authors
Abstract
Use of a steroid hormone or steroid hormone analogue and at least a portioUse of a steroid hormone or steroid hormone analogue and at least a portion of HPV E2 protein in the preparation of a pharmaceutical composition for the treatment of cervical cancer.n of HPV E2 protein in the preparation of a pharmaceutical composition for the treatment of cervical cancer.
Citation
Gaston, K. (2001). Combination of progesterone and mifepristone for cancer therapy
| Other Type | Other |
|---|---|
| Publication Date | 2001 |
| Deposit Date | Jan 24, 2019 |
| Public URL | https://nottingham-repository.worktribe.com/output/1037954 |
| Additional Information | PCT/GB01/01941 |
You might also like
Inhibition of Intimal Thickening By PRH (Proline-Rich Homeodomain) in Mice
(2023)
Journal Article
Targeting protein kinase CK2 in the treatment of cholangiocarcinoma
(2021)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search